{HEAD ~ A pharmaceutical composition} comprising at least one pharmaceutically acceptable carrier or {TAIL ~ adjuvant} and an effective TNF α release inhibiting amount of a substituted 2,4 imidazolidinedione compound corresponding to the formula I ##STR24## wherein R1 represents C1 6 alkyl or C3 6 cycloalkyl 
comprising
{ HEAD ~ A pharmaceutical composition } comprising at least one pharmaceutically acceptable carrier or { TAIL ~ adjuvant } and an effective TNF α release inhibiting amount of a substituted 2,4 imidazolidinedione compound corresponding to the formula I # # STR24 # # wherein R1 represents C1 6 alkyl or C3 6 cycloalkyl
HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH